Effect of oral citicoline therapy on retinal nerve fiber layer and ganglion cell-inner plexiform layer in patients with primary open angle glaucoma
- PMID: 35310047
- PMCID: PMC8907038
- DOI: 10.18240/ijo.2022.03.17
Effect of oral citicoline therapy on retinal nerve fiber layer and ganglion cell-inner plexiform layer in patients with primary open angle glaucoma
Abstract
Aim: To evaluate the short-term effects of oral citicoline therapy on the retinal nerve fiber layer (RNFL) and the macular ganglion cell-inner plexiform layer (mGCIPL) in patients with primary open angle glaucoma (POAG).
Methods: Fifty-four eyes of 54 patients with POAG glaucoma included in the study. In addition to a topical hypotensive, 250-mg oral citicoline was administered to 27 patients, while 27 patients were assigned as the control group. RNFL and mGCIPL values were measured using optical coherence tomography (OCT) at 1d before treatment and 3mo after the initiation of treatment. At the third month visit, citicoline treatment was discontinued and drug-free control (wash-out) measurements were obtained at the fourth month in citicoline group.
Results: The average RNFL thickness was significantly higher at month 3 than the baseline (P=0.038) in citicoline group. However, this improvement partially regressed after a 1-month wash-out period. No statistically significant changes in RNFL were observed in the superior, nasal, temporal and inferior quadrants at months 3 and 4 (P>0.05). The change in the average and inferior quadrant RNFL thickness in the citicoline group at 3mo was significantly greater than the control group (P=0.006 and P=0.014, respectively). There were no significant differences between the groups according to the change in mGCIPL thickness and the superior, nasal and temporal quadrant RNFL thickness (P>0.05).
Conclusion: With oral citicoline treatment, the loss in the average RNFL is prevented in POAG patients in the short-term. Study data show that citicoline may have a significant impact on slowing glaucoma progression, which could have a potential neuroprotective effect.
Keywords: citicoline; glaucoma; optical coherence tomography; retinal nerve fiber layer.
International Journal of Ophthalmology Press.
Figures


Similar articles
-
Efficacy of citicoline as a supplement in glaucoma patients: A systematic review.PLoS One. 2023 Sep 28;18(9):e0291836. doi: 10.1371/journal.pone.0291836. eCollection 2023. PLoS One. 2023. PMID: 37768938 Free PMC article.
-
Comparisons of ganglion cell-inner plexiform layer loss patterns and its diagnostic performance between normal tension glaucoma and primary open angle glaucoma: a detailed, severity-based study.Int J Ophthalmol. 2020 Jan 18;13(1):71-78. doi: 10.18240/ijo.2020.01.11. eCollection 2020. Int J Ophthalmol. 2020. PMID: 31956573 Free PMC article.
-
Macular inner plexiform and retinal nerve fiber layer thickness in glaucoma.Optom Vis Sci. 2014 Nov;91(11):1320-7. doi: 10.1097/OPX.0000000000000392. Optom Vis Sci. 2014. PMID: 25237762
-
Comparative analysis of mean retinal thickness measured using SD-OCT in normal young or old age and glaucomatous eyes.Int Ophthalmol. 2018 Dec;38(6):2417-2426. doi: 10.1007/s10792-017-0744-7. Epub 2017 Oct 12. Int Ophthalmol. 2018. PMID: 29027057
-
Temporal Relation between Macular Ganglion Cell-Inner Plexiform Layer Loss and Peripapillary Retinal Nerve Fiber Layer Loss in Glaucoma.Ophthalmology. 2017 Jul;124(7):1056-1064. doi: 10.1016/j.ophtha.2017.03.014. Epub 2017 Apr 10. Ophthalmology. 2017. PMID: 28408038
Cited by
-
Restored retinal physiology after administration of niacin with citicoline in a mouse model of hypertensive glaucoma.Front Med (Lausanne). 2023 Sep 5;10:1230941. doi: 10.3389/fmed.2023.1230941. eCollection 2023. Front Med (Lausanne). 2023. PMID: 37731716 Free PMC article.
-
Impact of Oral Citicoline, Antioxidant Vitamins, and Blackcurrant Supplementation on Primary Open-Angle Glaucoma: An OCT and OCTA Study.Biomedicines. 2025 May 31;13(6):1352. doi: 10.3390/biomedicines13061352. Biomedicines. 2025. PMID: 40564070 Free PMC article.
-
Efficacy of citicoline as a supplement in glaucoma patients: A systematic review.PLoS One. 2023 Sep 28;18(9):e0291836. doi: 10.1371/journal.pone.0291836. eCollection 2023. PLoS One. 2023. PMID: 37768938 Free PMC article.
-
Citicoline: pharmacological and clinical review, 2022 update.Rev Neurol. 2022 Nov 30;75(s05):S1-S89. doi: 10.33588/rn.75s05.2022311. Rev Neurol. 2022. PMID: 36544369 Free PMC article. Review. English, Spanish.
-
Combined use of coenzyme Q10 and citicoline: A new possibility for patients with glaucoma.Front Med (Lausanne). 2022 Dec 15;9:1020993. doi: 10.3389/fmed.2022.1020993. eCollection 2022. Front Med (Lausanne). 2022. PMID: 36590976 Free PMC article. Review.
References
LinkOut - more resources
Full Text Sources